Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Torii Pharmaceutical Co Ltd

4551
Current price
4 580 JPY +9.86 JPY (+0.22%)
Last closed 4 355 JPY
ISIN JP3635800000
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Tokyo Stock Exchange
Capitalization 125 078 900 374 JPY
Yield for 12 month +26.87 %
1Y
3Y
5Y
10Y
15Y
4551
21.11.2021 - 28.11.2021

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; CORECTIM, a topical janus kinase (JAK) inhibitor; and allergen immunotherapy tablets comprising CEDARCURE and MITICURE. In addition, it is engaged in real estate rental business. The company markets its products primarily through medical representatives for medical professionals. The company has a collaboaration with ALK-Abelló A/S to develop, market and distribute ALK's allergy immunotherapy tablet for the treatment of grass pollen allergy. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc. Address: Torii Nihonbashi Bldg., Tokyo, Japan, 103-8439

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

622 741.89 JPY

P/E ratio

24.0543

Dividend Yield

2.84 %

Current Year

+53 843 969 493 JPY

Last Year

+48 183 444 532 JPY

Current Quarter

+14 805 662 723 JPY

Last Quarter

+14 642 075 143 JPY

Current Year

+24 215 891 133 JPY

Last Year

+23 038 257 675 JPY

Current Quarter

+6 693 294 767 JPY

Last Quarter

+6 547 445 685 JPY

Key Figures 4551

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 6 847 766 702 JPY
Operating Margin TTM 10.11 %
PE Ratio 24.0543
Return On Assets TTM 3.04 %
PEG Ratio
Return On Equity TTM 4.42 %
Wall Street Target Price 622 741.89 JPY
Revenue TTM 57 983 917 262 JPY
Book Value 4 209.56 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.8 %
Dividend Yield 2.84 %
Gross Profit TTM 23 040 228 551 JPY
Earnings per share 184.97 JPY
Diluted Eps TTM 184.97 JPY
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 1.7 %
Profit Margin 8.97 %

Dividend Analytics 4551

Dividend growth over 5 years

150 %

Continuous growth

2 years

Payout Ratio 5 years average

49 %

Dividend History 4551

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 120
Ex Dividend Date 27.12.2024
Forward Annual Dividend Yield 2.76 %
Last Split Factor
Payout Ratio 69.24 %
Last Split Date
Dividend Date

Stock Valuation 4551

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 24.0543
Forward PE
Enterprise Value Revenue 1.4326
Price Sales TTM 2.1906
Enterprise Value EBITDA 12.1296
Price Book MRQ 1.0632

Financials 4551

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4551

For 52 weeks

3 059.88 JPY 4 508.51 JPY
50 Day MA 3 866.88 JPY
Shares Short Prior Month
200 Day MA 3 785.45 JPY
Short Ratio
Shares Short
Short Percent